Boothbay Fund Management, LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $766,003 - $900,235
11,900 New
11,900 $823,000
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $3.45 Million - $4.49 Million
78,800 New
78,800 $4.27 Million
Q2 2022

Aug 15, 2022
SELL
$43.0 - $65.64 $232,200 - $354,456
-5,400 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $689,572 - $1.11 Million
-17,800 Reduced 76.72%
5,400 $330,000
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $679,760 - $1.03 Million
23,200 New
23,200 $947,000

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $11.9B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email